Nutex Health (NASDAQ:NUTX) Shares Up 9.1% – Still a Buy?

Nutex Health Inc. (NASDAQ:NUTX) was up 9.1% during mid-day trading on Wednesday . The company traded as high as $184.40 and last traded at $186.4720. 125,047 shares changed hands during trading, a decline of 30% from the average daily volume of 178,992 shares. The stock had previously closed at $170.89.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Zacks Research raised shares of Nutex Health to a “hold” rating in a research note on Monday. Lake Street Capital initiated coverage on shares of Nutex Health in a report on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price target for the company. Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Wall Street Zen raised Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Finally, B. Riley Financial assumed coverage on Nutex Health in a research note on Friday, June 26th. They issued a “buy” rating and a $290.00 target price for the company. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, Nutex Health currently has an average rating of “Moderate Buy” and a consensus target price of $243.33.

Nutex Health Stock Performance

The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12. The stock’s 50 day simple moving average is $135.30 and its two-hundred day simple moving average is $130.02. The stock has a market cap of $1.35 billion, a P/E ratio of 15.19 and a beta of 0.21.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings results on Thursday, April 30th. The company reported $6.52 earnings per share for the quarter, beating the consensus estimate of $3.99 by $2.53. The company had revenue of $216.49 million during the quarter, compared to analysts’ expectations of $227.80 million. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. As a group, research analysts forecast that Nutex Health Inc. will post 22.72 EPS for the current year.

Institutional Investors Weigh In On Nutex Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Segall Bryant & Hamill LLC bought a new position in shares of Nutex Health in the 3rd quarter valued at $2,394,000. Topline Capital Management LLC grew its holdings in Nutex Health by 80.0% in the third quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock worth $57,505,000 after purchasing an additional 247,436 shares during the period. Pertento Partners LLP bought a new stake in shares of Nutex Health in the 3rd quarter worth approximately $27,940,000. Hussman Strategic Advisors Inc. purchased a new stake in Nutex Health in the 4th quarter worth about $3,457,000. Finally, SG Americas Securities LLC grew its stake in shares of Nutex Health by 3,232.6% during the first quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock valued at $2,885,000 after buying an additional 29,449 shares during the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.